CYTEK BIOSCIENCES, INC. (CTKB) Gross Margin
- Gross margin · 12 months: Value 53.23%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 53.23% | Gross profit / revenue. Period ending 2026-06-30. $110.03M ÷ $206.71M × 100 ≈ 53.23% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 110.03M USD | Gross Profit |
| Revenue | 206.71M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 96.68M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $110.03M | $206.71M | $96.68M | 53.23% |
| 2026-03-31 | $105.56M | $204.17M | $98.61M | 51.70% |
| 2025-12-31 | $104.46M | $201.49M | $97.03M | 51.84% |
| 2025-09-30 | $105.23M | $196.83M | $91.60M | 53.46% |
| 2025-06-30 | $106.68M | $196.03M | $89.35M | 54.42% |
| 2025-03-31 | $108.25M | $197.05M | $88.80M | 54.94% |
| 2024-12-31 | $111.11M | $200.45M | $89.35M | 55.43% |
| 2024-09-30 | $110.50M | $201.21M | $90.71M | 54.92% |
| 2024-06-30 | $108.67M | $197.71M | $89.04M | 54.97% |
| 2024-03-31 | $111.40M | $200.79M | $89.39M | 55.48% |
| 2023-12-31 | $109.43M | $193.01M | $83.59M | 56.69% |
| 2023-09-30 | $105.75M | $183.12M | $77.37M | 57.75% |
| 2023-06-30 | $105.44M | $175.59M | $70.16M | 60.05% |
| 2023-03-31 | $101.83M | $166.06M | $64.22M | 61.32% |
| 2022-12-31 | $100.97M | $164.04M | $63.06M | 61.56% |
| 2022-09-30 | $95.24M | $154.59M | $59.36M | 61.60% |
| 2022-06-30 | $89.65M | $148.49M | $58.84M | 60.37% |
| 2022-03-31 | $84.83M | $138.74M | $53.91M | 61.15% |
| 2021-12-31 | $79.14M | $127.95M | $48.81M | 61.86% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $51.71M | $92.84M | $41.13M | 55.70% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |